Skip to main content

Seres Therapeutics, Inc.

MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001609809

In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 39 institutions reported holding it in 13F filings for Q3 2026, worth $7.84M in total; no superinvestor holds it.

13F holders, Q3 2026

Institutional positions in Seres Therapeutics, Inc. as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
+5 vs. Q2 2026
Shares held
2.34M
+70.7K (+3.1%) vs. Q2 2026
Total value
$7.84M
−$10.1M (−56.2%) vs. Q2 2026
New holders
9
7 more added
Sold out
4
13 more reduced

1 institution that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MCRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2026: 39 institutions
Q1 2021: 154 institutionsQ2 2021: 148 institutionsQ3 2021: 133 institutionsQ4 2021: 148 institutionsQ1 2022: 131 institutionsQ2 2022: 123 institutionsQ3 2022: 120 institutionsQ4 2022: 124 institutionsQ1 2023: 123 institutionsQ2 2023: 138 institutionsQ3 2023: 134 institutionsQ4 2023: 103 institutionsQ1 2024: 99 institutionsQ2 2024: 93 institutionsQ3 2024: 77 institutionsQ4 2024: 69 institutionsQ1 2025: 63 institutionsQ2 2025: 33 institutionsQ3 2025: 32 institutionsQ4 2025: 36 institutionsQ1 2026: 33 institutionsQ2 2026: 35 institutionsQ3 2026: 39 institutions
Value heldQ3 2026: $7.84M
Q1 2021: $1.85BQ2 2021: $1.93BQ3 2021: $555.1MQ4 2021: $642.8MQ1 2022: $537.2MQ2 2022: $312.7MQ3 2022: $671.6MQ4 2022: $588.2MQ1 2023: $593.9MQ2 2023: $538.1MQ3 2023: $255.6MQ4 2023: $125.4MQ1 2024: $66.3MQ2 2024: $50.0MQ3 2024: $60.1MQ4 2024: $52.5MQ1 2025: $43.1MQ2 2025: $25.4MQ3 2025: $40.9MQ4 2025: $36.4MQ1 2026: $20.5MQ2 2026: $17.9MQ3 2026: $7.84M
Institutions holding MCRB and their total value by quarter
QuarterHoldersValue
Q3 202639$7.84M
Q2 202635$17.9M
Q1 202633$20.5M
Q4 202536$36.4M
Q3 202532$40.9M
Q2 202533$25.4M
Q1 202563$43.1M
Q4 202469$52.5M
Q3 202477$60.1M
Q2 202493$50.0M
Q1 202499$66.3M
Q4 2023103$125.4M
Q3 2023134$255.6M
Q2 2023138$538.1M
Q1 2023123$593.9M
Q4 2022124$588.2M
Q3 2022120$671.6M
Q2 2022123$312.7M
Q1 2022131$537.2M
Q4 2021148$642.8M
Q3 2021133$555.1M
Q2 2021148$1.93B
Q1 2021154$1.85B

Institutions, Q3 2026

Shares, value and share of portfolio for each institution holding Seres Therapeutics, Inc.; share changes are against Q2 2026.

Institutions holding MCRB in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Flagship Pioneering Inc.1,155,850$3.87M0.20%00.0%Unchanged
Vanguard Capital Management LLC286,405$959.5K0.00%−1,371−0.5%Reduced
Marshall Wace, LLP139,278$466.6K0.00%−32,967−19.1%Reduced
Jacobs Levy Equity Management, Inc134,375$450.2K0.00%+134,375New
Vontobel Holding Ltd.114,566$383.8K0.00%−8,409−6.8%Reduced
BlackRock, Inc.109,827$367.9K0.00%−1,173−1.1%Reduced
Geode Capital Management, LLC78,898$264.4K0.00%−1,076−1.3%Reduced
Susquehanna International Group, LLP62,692$210.0K0.00%+4,364+7.5%Added
Vanguard Fiduciary Trust Co48,685$163.1K0.00%00.0%Unchanged
State Street Corp33,901$113.6K0.00%00.0%Unchanged
Lion Point Capital, LP31,570$105.8K0.61%00.0%Unchanged
Goldman Sachs Group Inc17,888$59.9K0.00%+2,659+17.5%Added
Quadrature Capital Ltd17,428$58.4K0.00%+17,428New
J. Safra Sarasin Holding AG14,997$50.2K0.00%+14,997New
Northern Trust Corp14,750$49.4K0.00%−15−0.1%Reduced
Invesco Ltd.12,603$42.2K0.00%−371−2.9%Reduced
Morgan Stanley12,283$41.1K0.00%+145+1.2%Added
Renaissance Technologies LLC11,791$39.5K0.00%+11,791New
Squarepoint Ops LLC11,523$38.6K0.00%+11,523New
XTX Topco Ltd10,705$35.9K0.00%−10,027−48.4%Reduced
Group One Trading, L.P.3,714$12.4K0.00%00.0%Unchanged
SBI Securities Co., Ltd.3,601$12.1K0.00%−581−13.9%Reduced
UBS Group AG3,493$11.7K0.00%+3,009+621.7%Added
Tower Research Capital LLC (TRC)2,173$7.28K0.00%+1,857+587.7%Added
Vanguard Global Advisers, LLC1,975$6.62K0.00%00.0%Unchanged
Nuveen, LLC1,773$6.17K0.00%+1,773New
FMR LLC1,730$5.80K0.00%+202+13.2%Added
Rachor Investment Advisory Services, LLC1,185$3.97K0.00%−292−19.8%Reduced
JPMorgan Chase & Co746$2.60K0.00%−2,890−79.5%Reduced
Pinnacle Financial Group, Inc.300$1.00K0.00%+300New
BNP Paribas Arbitrage, SA214$7170.00%+3+1.4%Added
Continuum Advisory, LLC47$1570.00%00.0%Unchanged
The PNC Financial Services Group, Inc.23$770.00%+23New
Simplex Trading, LLC18$600.00%−4,580−99.6%Reduced
Wells Fargo & Company10$340.00%00.0%Unchanged
Advisor Group Holdings, Inc.8$260.00%00.0%Unchanged
Larson Financial Group LLC5$170.00%00.0%Unchanged
Allworth Financial LP4$140.00%+4New
Barclays PLC4$130.00%−163−97.6%Reduced
Charles Schwab Investment Management Inc0$00.00%−31,049−100.0%Sold out
American Century Companies Inc0$00.00%−28,313−100.0%Sold out
Citadel Advisors LLC0$00.00%−10,504−100.0%Sold out
Whittier Trust Co of Nevada Inc0$00.00%−1−100.0%Sold out
Royal Bank of Canada––––Not filed